###begin article-title 0
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 0 19 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Schistosoma mansoni Tegument Protein Sm29 Is Able to Induce a Th1-Type of Immune Response and Protection against Parasite Infection
###end article-title 0
###begin p 1
Current address: National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland, United States of America
###end p 1
###begin p 2
###xml 48 51 <span type="species:ncbi:12242?0.9253246753246753">TMV</span>
###xml 120 123 <span type="species:ncbi:12242?0.9253246753246753">TMV</span>
###xml 172 175 <span type="species:ncbi:12242?0.9253246753246753">TMV</span>
Conceived and designed the experiments: FCC GTA TMV SVA SCO. Performed the experiments: FCC GCM EG GTK VLM ALdM MVC GTA TMV. Analyzed the data: FCC GCM EG GTK ALdM MVC GTA TMV SVA SCO. Contributed reagents/materials/analysis tools: GTK SVA. Wrote the paper: FCC SVA SCO.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 395 415 395 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni.</italic>
###xml 102 108 <span type="species:ncbi:9606">people</span>
###xml 142 148 <span type="species:ncbi:9606">people</span>
###xml 395 414 <span type="species:ncbi:6183">Schistosoma mansoni</span>
###xml 551 557 <span type="species:ncbi:10090">murine</span>
Schistosomiasis continues to be a significant public health problem. This disease affects 200 million people worldwide and almost 800 million people are at risk of acquiring the infection. Although vaccine development against this disease has experienced more failures than successes, encouraging results have recently been obtained using membrane-spanning protein antigens from the tegument of Schistosoma mansoni. Our group recently identified Sm29, another antigen that is present at the adult worm tegument surface. In this study, we investigated murine cellular immune responses to recombinant (r) Sm29 and tested this protein as a vaccine candidate.
###end p 4
###begin title 5
Methods and Findings
###end title 5
###begin p 6
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
We first show that Sm29 is located on the surface of adult worms and lung-stage schistosomula through confocal microscopy. Next, immunization of mice with rSm29 engendered 51%, 60% and 50% reduction in adult worm burdens, in intestinal eggs and in liver granuloma counts, respectively (p<0.05). Protective immunity in mice was associated with high titers of specific anti-Sm29 IgG1 and IgG2a and elevated production of IFN-gamma, TNF-alpha and IL-12, a typical Th1 response. Gene expression analysis of worms recovered from rSm29 vaccinated mice relative to worms from control mice revealed a significant (q<0.01) down-regulation of 495 genes and up-regulation of only 22 genes. Among down-regulated genes, many of them encode surface antigens and proteins associated with immune signals, suggesting that under immune attack schistosomes reduce the expression of critical surface proteins.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
This study demonstrates that Sm29 surface protein is a new vaccine candidate against schistosomiasis and suggests that Sm29 vaccination associated with other protective critical surface antigens is the next logical strategy for improving protection.
###end p 8
###begin title 9
Author Summary
###end title 9
###begin p 10
###xml 421 440 421 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 421 440 <span type="species:ncbi:6183">Schistosoma mansoni</span>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 998 1002 <span type="species:ncbi:10090">mice</span>
Schistosomiasis is the most important human helminth infection in terms of morbidity and mortality. Although the efforts to develop a vaccine against this disease have experienced failures, a new generation of surface antigens revealed by proteomic studies changed this scenario. Our group has characterized the protein Sm29 described previously as one of the most exposed and expressed antigens in the outer tegument of Schistosoma mansoni. Studies in patients living in endemic areas for schistosomiasis revealed high levels of IgG1 and IgG3 anti-Sm29 in resistant individuals. In this study, confocal microscope analysis showed Sm29 present in the surface of lung-stage schistosoluma and adult worms. Recombinant Sm29, when used as vaccine candidate, induced high levels of protection in mice. This protection was associated with a typical Th1 immune response and reduction of worm burden, liver granulomas and in intestinal eggs. Further, microarray analysis of worms recovered from vaccinated mice showed significant down-regulation of several genes encoding previously characterized vaccine candidates and/or molecules exposed on the surface, suggesting an immune evasion strategy of schistosomes under immune attack. These results demonstrated that Sm29 as one of the important antigens with potential to compose a vaccine against schistosomiasis.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 247 250 247 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-vanderWerf1">[1]</xref>
###xml 359 362 359 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Steinmann1">[2]</xref>
###xml 385 388 385 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-King1">[3]</xref>
###xml 696 699 696 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Harder1">[4]</xref>
###xml 866 869 866 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Bergquist1">[5]</xref>
###xml 1035 1038 1035 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Bergquist2">[6]</xref>
###xml 1172 1175 1172 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Chitsulo1">[7]</xref>
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 188 194 <span type="species:ncbi:9606">people</span>
###xml 672 678 <span type="species:ncbi:9606">people</span>
Schistosomiasis mainly occurs in developing countries and is the most important human helminth infection in terms of global mortality. This parasitic disease affects more than 200 million people worldwide causing more than 250,000 deaths per year [1]. Furthermore, schistosomiasis causes up to 4.5 million DALY (disability adjusted life year) losses annually [2]. Recently, King et al [3] have associated schistosomiasis with anemia, pain, diarrhea, exercise intolerance, and under-nutrition that results from chronic infection. Current schistosomiasis control strategies are mainly based on chemotherapy but, in spite of decades of mass treatment, the number of infected people remains constant [4]. Extensive endemic areas and constant reinfection of individuals together with poor sanitary conditions in developing countries make drug treatment alone inefficient [5]. Many consider that the best long-term strategy to control schistosomiasis is through immunization with an anti-schistosomiasis vaccine combined with drug treatment [6]. A vaccine that induces even a partial reduction in worm burdens could considerably reduce pathology and limit parasite transmission [7].
###end p 12
###begin p 13
###xml 49 52 49 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Cardoso1">[8]</xref>
###xml 404 414 404 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 498 501 498 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Gobert1">[9]</xref>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-VerjovskiAlmeida1">[10]</xref>
###xml 534 544 534 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 660 664 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Braschi1">[11]</xref>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
###xml 404 414 <span type="species:ncbi:6183">S. mansoni</span>
###xml 534 544 <span type="species:ncbi:6183">S. mansoni</span>
###xml 783 787 <span type="species:ncbi:10090">mice</span>
Sm29 protein has been characterized by our group [8], proving to be a membrane-bound antigen on adult worms that is strongly recognized by IgG1 and IgG3 antibodies of naturally resistant individuals and patients resistant to re-infection living in endemic areas for schistosomiasis in Brazil. Recent studies, using microarrays and RT-PCR, showed that Sm29 is among the 16% most highly expressed genes in S. mansoni, and probably serves an important function in the surface biology of this parasite [9],[10]. Proteomic analysis of the S. mansoni tegument composition identified Sm29 as one of the integral proteins to be consistently found in the outer surface [11]. Therefore, the next step would be to investigate humoral and cellular immune responses induced by Sm29 in vaccinated mice and protection studies.
###end p 13
###begin p 14
###xml 108 118 108 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 108 118 <span type="species:ncbi:6183">S. mansoni</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
Herein, we determined that Sm29 is present on the tegument of lung-stage and male and female adult worms of S. mansoni by confocal microscopy. Besides, rSm29 induced a Th1-type of immune response in mice and reduction in worm burden and liver pathology.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and parasites
###end title 16
###begin p 17
###xml 249 259 249 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 301 322 301 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Biomphalaria glabrata</italic>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 249 259 <span type="species:ncbi:6183">S. mansoni</span>
###xml 301 322 <span type="species:ncbi:6526">Biomphalaria glabrata</span>
C57BL/6 and TLR4 KO female mice, 6-8 weeks old, were obtained from the Federal University of Minas Gerais (UFMG) animal facility. All procedures involving animals were approved by the local Ethics Committee on Animal Care (CETEA-UFMG). Cercariae of S. mansoni (LE strain) were maintained routinely in Biomphalaria glabrata snails at Rene Rachou Research Center (Fiocruz, Brazil) and prepared by exposing infected snails to light for 2 hrs to induce shedding of parasites. Cercarial numbers and viability were determined using a light microscope prior to infection. The protocols involving animals used in this study were approved by the Federal University of Minas Gerais Ethics Committee in Animal Experimentation (CETEA No. 023/2005).
###end p 17
###begin title 18
Antigen preparation
###end title 18
###begin p 19
###xml 71 74 71 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Cardoso1">[8]</xref>
###xml 152 158 152 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 152 158 <span type="species:ncbi:110766|species:ncbi:562">E.coli</span>
The recombinant Sm29 was produced and purified as described previously [8]. Briefly, the Sm29 cDNA fused with a C-terminal 6x histidine was produced in E.coli using the pET21a expression vector (Novagen, NJ, USA). The recombinant Sm29 was purified in an affinity column and dialyzed against PBS pH 7.0.
###end p 19
###begin title 20
###xml 78 85 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mansoni</italic>
###xml 75 85 <span type="species:ncbi:6183">S. mansoni</span>
Immunolocalization of Sm29 in male, female and lung-stage schistosomula of S. mansoni
###end title 20
###begin p 21
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Harrop1">[12]</xref>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 641 646 <span type="species:ncbi:10090">mouse</span>
###xml 1277 1282 <span type="species:ncbi:10090">mouse</span>
Adult worms used in confocal microscopy studies were recovered from perfused mice and lung-stage schistosomula were prepared according to the method described by Harrop & Wilson [12]. Parasites fixed in Omnifix II (Ancon Genetics, St Petersburg, FL, USA) were used in whole mount or in section assays. For sections assays, 7 mum slices were deparaffinized with xylol series. Parasites were blocked with 1% BSA in PBST (Tween 20 0.05%) for 1 hr and incubated with anti-rSm29 serum diluted 1:20 in blocking buffer. Serum from non-immunized mice was used as a negative control. Samples were washed three times with PBST and incubated with anti-mouse IgG antibody conjugated to Alexa Fluor 594 (Molecular Probes, CA, USA) diluted 1:100 in blocking buffer containing Phalloidin Alexa Fluor 488 (Molecular Probes) to stain actin microfilaments. The samples were washed four times and mounted in antifade reagent (Prolong gold-Molecular Probes). For whole mount assays, parasites were blocked with 1% BSA, 0.1% Triton X-100, 0.1% azide in PBS for two hours at 4degreesC under agitation. Blocked parasites were incubated with anti-Sm29 serum diluted 1:80 in the blocking buffer during 16hrs at 4degreesC under agitation. Samples were washed six times with PBST and incubated with anti-mouse and phalloidin, both diluted 1:300, during 4 hours at 4degreesC under agitation. The samples were washed five times and mounted in 90% glycerol and 10% TRIS, pH 9.0. The parasites were visualized in a Zeiss 510 Meta confocal microscope using an immersion objective. All the parameters and microscope settings used were maintained throughout the process.
###end p 21
###begin title 22
Tegument purification
###end title 22
###begin p 23
###xml 24 45 24 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Biomphalaria glabrata</italic>
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-RamalhoPinto1">[13]</xref>
###xml 843 844 831 832 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 24 45 <span type="species:ncbi:6526">Biomphalaria glabrata</span>
Cercariae obtained from Biomphalaria glabrata snails exposed to light for two hours were transformed mechanically in skin-stage schistosomula according to Ramalho-Pinto et al [13]. First, cercariae were incubated on ice for 30 minutes and centrifuged for 3 minutes, 1000 rpm, 4degreesC. The cercariae were resuspended in 1ml of cold ELAC (Earle's salts plus lactalbumin hydrolysate) contain 0.5% lacto albumin, 1% penicillin/streptomycin and 0.17% glucose. The tails were broken by vortex in high speed during 2 minutes. After this, the tails were removed through six washes with ELAC. The schistosomula were incubated for 1 hour and 30 minutes at 37degreesC in ELAC and washed with apyrogenic physiologic saline. For the tegument removal, the schistosomula were submitted to vortex using high speed, two times of eight minutes each, in a CaCl2 0.3 M solution. The sample was centrifuged at 1000 rpm for 1 minute. The supernatant was collected and centrifuged at 26500 rpm for 1 hour at 4degreesC. The pellet was dialyzed against physiologic saline 1.7%.
###end p 23
###begin title 24
Western blot analysis
###end title 24
###begin p 25
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 471 476 <span type="species:ncbi:10090">mouse</span>
Two micrograms of purified skin-stage schistosomula tegument were submitted to SDS- PAGE 12%, transferred to a nitrocellulose membrane (Millipore) and blocked 16 hours at room temperature with TBST (0.5M NaCl, 0.02M Tris pH 7.5, 0.05% tween, 5% skim milk). The membranes were washed tree times with TBST and probed with anti-Sm29 or naive mice serum diluted 1:500 in TBST for 4 hours at room temperature. The membranes were washed six times and probed one hour with anti-mouse IgG conjugated to alkaline phosphatase (Invitrogen) diluted 1:10000 in TBST. After six washes, the membranes were developed using ECF subtract (GE Healthcare) and visualized in a Storm apparatus (GE Healthcare).
###end p 25
###begin title 26
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Immunization of mice
###end title 26
###begin p 27
###xml 269 273 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Fonseca1">[14]</xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 89 93 <span type="species:ncbi:10090">Mice</span>
###xml 365 368 <span type="species:ncbi:31658">CFA</span>
Six to eight week old female C57BL/6 mice were divided into two groups of ten mice each. Mice were subcutaneously injected in the nape of the neck with 25 mug rSm29 on days 0, 15 and 30. Sm29 protein concentration for vaccination was determined as previously described [14]. The recombinant protein was formulated with Freund's adjuvant (complete Freund's adjuvant/CFA for the first immunization and incomplete Freund's adjuvant/IFA for the boosters). In the control group, PBS with Freund's adjuvant was administered using the same immunization protocol.
###end p 27
###begin title 28
Challenge infection and worm burden recovery
###end title 28
###begin p 29
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Fifteen days after the last boost, mice were challenged through percutaneous exposure of abdominal skin for 1 h in water containing 100 cercariae (LE strain). Forty-five days after challenge, adult worms were perfused from the portal veins. Two independent experiments were performed to determine protection levels. The protection was calculated by comparing the number of worm recovered from each vaccinated group with its respective control group, using the formula:where PL = protection level, WRCG = worms recovered from control group, and WREG = worms recovered from experimental group.
###end p 29
###begin title 30
Oogram and histophatological analysis
###end title 30
###begin p 31
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Pacheco1">[15]</xref>
Following perfusion for the recovery of the schistosomes, fragments of the intestine (terminal ileum) from each animal were separated and transferred to the Petri dishes containing saline as previously demonstrated [15]. The intestines were opened lengthwise and the excess mucus was removed. One-centimeter fragments were weighed and placed between a glass slide and a plastic cover. The preparation was inverted and pressed on a rubber surface padded with filter paper. Then, the slices were examined with a microscope (100 x) and all the eggs were counted. Quantitative oograms were obtained, using the formula: number of eggs/grams of tissue = number of eggs in intestinal fragment/weight of fragment in mg. A qualitative oogram evaluation was performed, in which the developmental stages of the eggs were classified as described previously.
###end p 31
###begin p 32
The liver fragments were collected from the same animals analyzed in oogram studies and fixed in 10% paraformaldehyde. The fragments were processed for paraffin embedding and histopathological sections performed using microtome at 6-7 mum and stained in a slide with hematoxilin-eosin (HE). The number of granulomas was obtained from the liver sections using 10x objective in a microscope. The area from each liver section was calculated using capture in scanner followed by analysis in the KS300 software connected to a Carl Zeiss image analyzer.
###end p 32
###begin title 33
Measurement of specific anti-Sm29 antibodies
###end title 33
###begin p 34
###xml 867 868 858 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</italic>
###xml 932 933 923 924 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 934 935 925 926 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 471 477 <span type="species:ncbi:9913">bovine</span>
###xml 671 676 <span type="species:ncbi:10090">mouse</span>
Following immunization, sera of ten mice from each experimental group were collected at two-week intervals. Measurement of specific anti-Sm29 antibodies was performed using indirect ELISA. Maxisorp 96-well microtiter plates (Nunc, Denmark) were coated with 5 mug/ml rSm29 in carbonate-bicarbonate buffer, pH 9.6 for 16 h at 4degreesC, then blocked for 2 at room temperature with 200 mul/well PBST (phosphate buffer saline, pH 7.2 with 0.05% Tween-20) plus 10% FBS (fetal bovine sera). One hundred microliters of each serum diluted 1:100 in PBST was added per well and incubated for 1 h at room temperature. Plate-bound antibody was detected by peroxidase-conjugated anti-mouse IgG, IgG1 and IgG2a (Southern Biotechnology, CA, USA) diluted in PBST 1:10000, 1:5000 and 1:2000, respectively. Color reaction was developed by addition of 100 mul per well of 200 pmol OPD (o-phenylenediamine, Sigma) in citrate buffer, pH 5.0 plus 0.04% H2O2 for 10 min and stopped with 50 mul of 5% sulfuric acid per well. The plates were read at 495 nm in an ELISA plate reader (BioRad, Hercules, CA).
###end p 34
###begin title 35
Cytokine analysis
###end title 35
###begin p 36
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 327 328 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 699 703 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Fonseca1">[14]</xref>
###xml 704 708 693 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Pacfico1">[16]</xref>
###xml 792 793 775 776 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 957 961 939 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Cardoso2">[17]</xref>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 109 112 <span type="species:ncbi:31658">CFA</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
Cytokine experiments were performed using splenocyte cultures from individual mice immunized with rSm29 plus CFA/IFA (n = 5 for each group). Splenocytes were isolated from macerated spleens of individual mice 10 days after the third immunization and washed twice with sterile PBS. After washing, the cells were adjusted to 1x106 cells per well for IL-4, IL-10, IFN-gamma and TNF-alpha assays in RPMI 1640 medium (Gibco, CA, USA) supplemented with 10% FBS, 100 U/ml penicillin G sodium, 100 mug/ml streptomycin sulfate, 250 ng/ml amphotericin B. Splenocytes were maintained in culture with medium alone or stimulated with rSm29 (25 mug/ml) or concanavalin A (ConA) (5 mug/ml) as previously described [14],[16]. The 96-well plates (Nunc) were maintained in an incubator at 37degreesC with 5% CO2. For cytokine assays polymyxin B (30 mug/ml) was added to the cultures and this treatment completely abrogate the cytokine response to LPS as previously described [17]. Culture supernatants were collected after 24 h of ConA stimulation, 48 h of rSm29 stimulation for IL-4 and TNF-alpha analysis and 72 h of rSm29 stimulation for IL-10 and IFN-gamma. The assays for measurement of IL-4, IL-10, IFN-gamma and TNF-alpha were performed using the Duoset ELISA kit (R&D Diagnostic) according to the manufacturer's directions.
###end p 36
###begin p 37
###xml 284 285 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 555 562 553 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 555 562 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Innate immune responses were assessed using peritoneal macrophages culture obtained from C57BL/6 and TLR4 KO mice that had received an intra-peritoneal injection of thioglycolate four days earlier. The macrophages were recovered through peritoneal washes with PBS and adjusted to 1x106 cells per well for IL-12p40 assays in RPMI 1640 medium (Gibco) supplemented with 5% FBS, 100U/ml penicillin G sodium and 100 mug/ml streptomycin sulfate. Macrophages were maintained in culture with medium alone or stimulated with rSm29 (25 mug/ml) or LPS purified from E. coli (1 mug/ml). Culture supernatants were collected after 24 hrs of stimulation. The assays for measurement of IL-12p40 were performed using the Duoset ELISA kit (R&D Diagnostic) according to the manufacturer's directions.
###end p 37
###begin title 38
###xml 42 52 42 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 42 52 <span type="species:ncbi:6183">S. mansoni</span>
Microarray analysis of gene expression in S. mansoni worms
###end title 38
###begin p 39
Total RNA was obtained using Trizol reagent (Invitrogen) according to the manufacturer's instructions. RNA was quantified using the Nanodrop ND-1000 UV/Vis spectrophotometer and RNA integrity was checked by electrophoresis with an Agilent 2100 Bioanalyzer. One microgram of total RNA from each sample was amplified using the T7-RNA polymerase-based linear amplification protocol. Three micrograms of aminoallyl-modified amplified RNA was labeled with Cy3 or Cy5 by indirect labeling (GE Healthcare).
###end p 39
###begin p 40
###xml 228 232 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-DeMarco1">[18]</xref>
###xml 707 717 700 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 740 744 733 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-VerjovskiAlmeida2">[19]</xref>
###xml 707 717 <span type="species:ncbi:6183">S. mansoni</span>
The Cy3- and Cy5-labeled RNA samples were combined and hybridized overnight to cDNA microarray slides using ASP hybridization chambers (GE Healthcare) at 42degreesC and the protocols were followed as recommended by manufacturer [18]. Slides were scanned at 5 mum resolution, 100% laser power (GenePix 4000B, Molecular Devices, USA) and PMT levels were adjusted in order to obtain similar average intensities of red and green signals. Each array contained 4,000 different elements, spotted in duplicate on the left and the right sides of a glass slide (GEO accession: GPL3929). The cDNA clones spotted on the arrays were selected to represent 4,000 unique transcripts that were identified in the large-scale S. mansoni transcriptome project [19].
###end p 40
###begin p 41
###xml 768 772 768 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-DeMarco1">[18]</xref>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
RNA from the pool of adult worms recovered from mice that had been immunized with the rSm29 vaccine (test sample) was hybridized against RNA from control adult worms recovered from mice treated only with adjuvant (control sample). Each assay consisted of two separate hybridizations, the first with Cy5-labeled test sample and Cy3-labeled control, and the second with dye-swap in order to account for dye bias; for each probe, the intensity of the test sample was computed as the average intensity of the Cy5 and Cy3 measurements; the same was computed for the control sample. Each assay provided two average values for the test and two for the control, arising from the duplicated copies of each gene that are spotted on the left and right halves of the glass slides [18]. A total of four hybridizations were performed, corresponding to two sets of technical replicate assays. Thus, a total of four different average intensity values for the test and four for the control sample were obtained for each probe on the array.
###end p 41
###begin p 42
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Yang1">[20]</xref>
###xml 282 283 282 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 591 595 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Tusher1">[21]</xref>
###xml 977 981 975 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Larsson1">[22]</xref>
Data was extracted from images using the Array Vision 8.0 program. We used a locally weighted linear regression (LOWESS) algorithm to correct for systematic bias due to small differences in the labeling and/or detection efficiencies between the fluorescent dyes [20]. Normalized log2 ratios of the intensities of test/control were used for the statistical analysis with the Significance Analysis of Microarrays tool (SAM) using a 0.14% false discovery rate (FDR), which corresponds to a q-value (analogous to the t-test p-value) of q<0.01, to find significant differentially expressed genes [21]. Genes determined in the previous step were filtered using a median fold-change >/=1.5 as cutoff, where fold-change = 2ˆ|log2 (test/control)|. The fold-change filter was applied after identification of significant differentially expressed genes with the use of SAM, therefore avoiding the bias caused by the use of arbitrary thresholds to trim datasets before significance testing [22].
###end p 42
###begin title 43
Putative identity of regulated genes
###end title 43
###begin p 44
###xml 122 125 122 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;10</sup>
Regulated genes were manually annotated by similarity using BLASTx and the GenBank nr database with a cut-off e-value = 10-10. Sequences were placed into four categories according to the similarity matches, as follows: tegument proteins, membrane proteins, receptor interacting proteins, lipid metabolism and other functions.
###end p 44
###begin title 45
Real-time RT-PCR
###end title 45
###begin p 46
###xml 389 397 386 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pntd.0000308.s003">Table S2</xref>
###xml 1171 1172 1117 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1231 1232 1177 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Total RNA was extracted with Trizol reagent (Invitrogen), according to the manufacturer's instructions. RNA samples were treated with DNAse, purified and concentrated using RNeasy Micro Kit (QIAGEN), following the manufacturer instructions and 1.5 mug of each sample was reverse transcribed using the SuperScript(R) III First-Strand Synthesis SuperMix (Invitrogen). Specific primer pairs (Table S2) were designed by Primer Express Program using default parameters (Applied Biosystem) and arbitrarily named primers 1 and 2. Real-time RT-PCRs were run in triplicates in a volume of 20 mul containing 10 mul of Sybr Green PCR Master Mix (Applied Biosystem), 160 nmol of each primer (primers 1 and 2), 0.30 mul cDNA from reverse transcription. Real-time RT-PCR was performed with the 7300 Real-Time PCR System (Applied Biosystem) using the following cycling parameters: 60degreesC for 10 min, 95degreesC for 10 min, 40 cycles of 95degreesC for 15 sec and 60degreesC for 1 min, and a dissociation stage of 95degreesC for 15 sec, 60degreesC for 1 min, 95degreesC for 15 sec, 60degreesC for 15 sec. Real time data was normalized in relation to the level of expression of actin. p-values were determined for the triplicates with Student's t-test, using one tail distribution and heteroscedastic variance.
###end p 46
###begin title 47
Microarray data public deposition information
###end title 47
###begin p 48
All microarray data were deposited in the GEO public database under Accession No. GSE10777.
###end p 48
###begin title 49
Statistical analysis
###end title 49
###begin p 50
###xml 50 52 50 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t-</italic>
Statistical analysis was performed with Student's t-test for comparison between two experimental groups using the software package GraphPad Prism.
###end p 50
###begin title 51
Results
###end title 51
###begin title 52
###xml 30 40 30 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 30 40 <span type="species:ncbi:6183">S. mansoni</span>
Sm29 is a tegument protein of S. mansoni
###end title 52
###begin p 53
###xml 142 152 142 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 200 207 200 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 316 326 316 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 328 344 328 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000308-g001">Fig. 1A, B, C, D</xref>
###xml 350 358 350 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pntd.0000308.s004">Video S1</xref>
###xml 448 455 448 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000308-g001">Fig. 1E</xref>
###xml 552 562 552 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 564 573 564 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pntd.0000308.s001">Figure S1</xref>
###xml 663 666 663 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Cardoso1">[8]</xref>
###xml 826 832 826 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000308-g002">Fig. 2</xref>
###xml 142 152 <span type="species:ncbi:6183">S. mansoni</span>
###xml 200 207 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 316 326 <span type="species:ncbi:6183">S. mansoni</span>
###xml 552 562 <span type="species:ncbi:6183">S. mansoni</span>
In the present study, we demonstrated the localization of Sm29 in the male and female adult worms and also in the lung-stage schistosomula of S. mansoni using specific antibodies to rSm29 produced in E. coli. The native Sm29 was located exclusively on the surface of lung-stage schistosomula and male adult worms of S. mansoni (Fig. 1A, B, C, D, and Video S1). The female adult worm showed Sm29 located on the surface and also in internal tissues (Fig. 1E). Confocal microscopy analysis also revealed that Sm29 is not present in the cercariae stage of S. mansoni (Figure S1), as expected from the absence of mRNA coding for this antigen in cercariae cDNA library [8]. Additionally, we detected Sm29 in the purified tegument fraction of the skin-stage schistosomula by western blot analysis using specific antibodies to rSm29 (Fig. 2).
###end p 53
###begin title 54
###xml 97 107 97 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 97 107 <span type="species:ncbi:6183">S. mansoni</span>
Immunolocalization of Sm29 antigen on male and female adult worm and lung-stage schistosomula of S. mansoni.
###end title 54
###begin p 55
###xml 435 446 435 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni.</italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 435 445 <span type="species:ncbi:6183">S. mansoni</span>
Polyclonal anti-Sm29 antibodies, serum from mice that received Freund́s adjuvant as negative control, and Cy5-conjugated anti-mice IgG were used. Actin was visualized by falloidin-Alexa fluor 488. The parasites were fixed in Omnifix II and used to whole-mount or section immunolocalization. (A and B) Whole-mount immunolocalization of Sm29 antigen on the surface (outer tegument) of male adult worm and (C) lung-stage schistosomula of S. mansoni. (D) Immunolocalization of Sm29 on the surface (outer tegument) of male adult worm, and (E) on the surface (outer tegument) and in some internal tissues on the female adult worm using deparaffinized sections of the parasites. Localization of Sm29 is identified by the orange color and actin filaments by the green color.
###end p 55
###begin title 56
Identification of Sm29 on skin-stage schistosomula tegument by Western blot.
###end title 56
###begin p 57
###xml 222 226 <span type="species:ncbi:10090">mice</span>
Two micrograms of purified skin-stage schistosomula tegument was applied onto 12% SDS-PAGE and transferred to a nitrocellulose membrane by western blot. After that, the membrane was probed with serum from rSm29 vaccinated mice or naive animals diluted 1:500 in TBST. Arrow indicates the native Sm29. The molecular mass markers, from top to bottom, are: 97, 66, 45, 30, 20.1, and 14.4 kDa.
###end p 57
###begin title 58
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Antibody profile following mice immunization
###end title 58
###begin p 59
###xml 269 277 269 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000308-g003">Figure 3</xref>
###xml 523 530 523 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000308-t001">Table 1</xref>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
To evaluate the level of specific IgG, IgG1 and IgG2a antibodies to Sm29 sera from ten vaccinated animals of each group were tested by ELISA. Significant titers of specific anti-Sm29 IgG antibodies were detected at all time points studied after the first immunization (Figure 3). In order to determine the IgG isotype profile induced by vaccination, specific anti-Sm29 IgG1 and IgG2a antibodies levels were also evaluated. The levels of specific IgG1 and IgG2a increased at 15, 30 and 45 days after the first immunization (Table 1). Furthermore, IgG1/IgG2a ratio was reduced at days 30 and 45 that parallels with elevated anti-Sm29 IgG2a production. The IgG1/IgG2a ratio observed in mice immunized with rSm29 can lead us to speculate that a Th1 type of immune response was induced following vaccination.
###end p 59
###begin title 60
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Kinetics of specific anti-Sm29 IgG induced in mice immunized with rSm29.
###end title 60
###begin p 61
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
Sera of ten immunized mice per group were collected at days 15, 30, 45, and 90 after the first immunization and assayed by ELISA. Arrows indicate the timing of vaccination. Results are presented as the mean absorbance measured at 492nm for each group. Results represent the mean of two independent experiments. Statistically significant differences of vaccinated mice compared to PBS+adjuvant control group is denoted by one asterisk for (p<0.05).
###end p 61
###begin title 62
IgG1 and IgG2a immune profile induced by vaccination with recombinant Sm29.
###end title 62
###begin p 63
Days after the first immunization
###end p 63
###begin p 64
Statistically significant compared to group of animals immunized with PBS with p<0.05
###end p 64
###begin title 65
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Vaccination induces a Th1-type of immune response in mice
###end title 65
###begin p 66
###xml 109 116 101 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000308-t002">Table 2</xref>
###xml 295 299 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Cardoso2">[17]</xref>
###xml 444 450 432 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000308-g004">Fig. 4</xref>
###xml 603 613 591 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 725 729 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Wynn1">[23]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
###xml 603 613 <span type="species:ncbi:6183">S. mansoni</span>
Mice vaccinated with rSm29 showed elevated production of IFN-gamma, TNF-alpha and IL-10 and absence of IL-4 (Table 2). Cultures used for measuring the cytokines were treated with polymyxin B to avoid non-specific stimulation due to eventual LPS contamination in the purified recombinant protein [17]. Additionally, rSm29 has stimulated peritoneal macrophages from C57BL/6 (2016+/-423 pg/ml) or TLR4 KO (1108+/-197 pg/ml) mice to produce IL-12 (Fig. 4). It is worth to emphasize that rSm29 has activated macrophages to secrete IL-12 which drives Th1 cell development. Protective immunity in mice against S. mansoni infection, before the onset of egg production, is thought to be the result of a Th1 pattern of immune response [23].
###end p 66
###begin title 67
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Sm29 induces IL-12 and TNF-alpha production by macrophages from TLR4 knockout mice.
###end title 67
###begin p 68
###xml 182 189 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 182 189 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Levels of IL-12 (p40) (A) or TNF-alpha (B) were measured in the supernatants of inflammatory macrophages from TLR4 KO or wild-type mice stimulated for 24 hrs with rSm29 (25 mug/ml), E. coli LPS (1 mug/ml) or medium alone. Significant differences from stimulated TLR4 KO or C57BL/6 macrophages in relation to non-stimulated cells are denoted by an asterisk (*) for p<0.05.
###end p 68
###begin title 69
###xml 151 170 151 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 151 170 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Parasitologic data, cytokine profile, intestinal egg counts and liver granuloma analysis of C57BL/6 mice vaccinated with rSm29 and challenged with 100 Schistosoma mansoni cercariae.
###end title 69
###begin p 70
This Table shows one experiment representative of two independent trials with similar results
###end p 70
###begin p 71
###xml 57 58 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistically significant compared to the control group (p<0.05)
###end p 71
###begin title 72
rSm29 engenders protective immunity
###end title 72
###begin p 73
###xml 154 164 154 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 277 287 277 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 534 541 534 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000308-t002">Table 2</xref>
###xml 682 685 682 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Chitsulo1">[7]</xref>
###xml 138 144 <span type="species:ncbi:10090">murine</span>
###xml 154 164 <span type="species:ncbi:6183">S. mansoni</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 277 287 <span type="species:ncbi:6183">S. mansoni</span>
###xml 361 365 <span type="species:ncbi:10090">Mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
To test the vaccine potential of rSm29 against schistosomiasis, we investigated the protection induced by this recombinant antigen in the murine model of S. mansoni infection. C57BL/6 mice were immunized three times with adjuvant-formulated rSm29, and then challenged with 100 S. mansoni cercariae. Control groups received adjuvanted phosphate-buffered saline. Mice vaccinated with rSm29 showed 51% reduction in adult worm burden, 60% reduction in intestinal eggs and 50% reduction in liver granuloma counts compared to control mice (Table 2). The most critical points to be considered about an efficient anti-schistosomiasis vaccine are the reduction in pathology and transmission [7], aspects that are present in the protection profile induced by rSm29 vaccine.
###end p 73
###begin title 74
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Gene expression profile in worms from vaccinated mice
###end title 74
###begin p 75
###xml 59 69 59 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 249 257 249 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pntd.0000308.s002">Table S1</xref>
###xml 882 889 882 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000308-t003">Table 3</xref>
###xml 1149 1157 1146 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000308-g005">Figure 5</xref>
###xml 1306 1313 1303 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000308-t003">Table 3</xref>
###xml 1318 1326 1315 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000308-g005">Figure 5</xref>
###xml 59 69 <span type="species:ncbi:6183">S. mansoni</span>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 1367 1371 <span type="species:ncbi:10090">mice</span>
In order to investigate the impact of rSm29 vaccination on S. mansoni, worms that were recovered from vaccinated mice had their gene expression profile analyzed using microarrays. This analysis revealed significant (q<0.01) regulation of 517 genes (Table S1) in worms recovered from mice vaccinated with adjuvanted rSm29 when compared to control mice injected with adjuvanted phosphate-buffered saline; of these, 495 genes (96%) were down-regulated and only 22 genes (4%) were up-regulated. Among down-regulated genes, several of them caught our attention and they fell into four major categories: tegument proteins (Sm23 and CD36-like class B scavenger receptor), membrane proteins (tetraspanin TE736), lipid metabolism (Sm14), receptor interacting proteins (B-cell receptor-associated protein and TGF-beta receptor interacting protein) and others (superoxide dismutase and Sm65) (Table 3). To validate the microarray data, we selected six genes (Sm23, Sm14, superoxide dismutase, CD36-like class B scavenger receptor, B-cell receptor-associated protein and TGF-beta receptor interacting protein) and performed real-time RT-PCR. As demonstrated in Figure 5, real-time RT-PCR of all six tested genes confirmed the reduced expression previously determined by microarray analysis. Based on the data shown in Table 3 and Figure 5, we hypothesize that in rSm29 protected mice a reduced expression of these critical surface antigens enables the parasites to adapt to the host in the face of an ongoing antiparasite immune response developed in vaccinated animals.
###end p 75
###begin title 76
###xml 46 56 46 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 46 56 <span type="species:ncbi:6183">S. mansoni</span>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Transcript level changes in selected genes of S. mansoni worms recovered from mice vaccinated with rSm29.
###end title 76
###begin p 77
###xml 88 98 88 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 303 313 303 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 357 367 357 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 408 418 408 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 451 461 451 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 518 529 512 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. sinensis</italic>
###xml 592 602 586 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 88 98 <span type="species:ncbi:6183">S. mansoni</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 303 313 <span type="species:ncbi:6183">S. mansoni</span>
###xml 357 367 <span type="species:ncbi:6183">S. mansoni</span>
###xml 408 418 <span type="species:ncbi:6183">S. mansoni</span>
###xml 451 461 <span type="species:ncbi:6183">S. mansoni</span>
###xml 518 529 <span type="species:ncbi:79923|species:ncbi:50994|species:ncbi:57402|species:ncbi:217758|species:ncbi:184112|species:ncbi:143401|species:ncbi:429258|species:ncbi:486199|species:ncbi:165091|species:ncbi:457837|species:ncbi:241807|species:ncbi:49123|species:ncbi:388262|species:ncbi:40937|species:ncbi:63053|species:ncbi:84243|species:ncbi:89484|species:ncbi:120566|species:ncbi:46218|species:ncbi:4442|species:ncbi:334431|species:ncbi:36622|species:ncbi:76391|species:ncbi:72228|species:ncbi:2711|species:ncbi:264042|species:ncbi:222085|species:ncbi:128511">C. sinensis</span>
###xml 592 602 <span type="species:ncbi:6183">S. mansoni</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
The figure shows real-time RT-PCR validation experiment for six genes down-regulated in S. mansoni worms recovered from rSm29+adjuvant immunized mice (black bars) compared to worms from PBS+adjuvant injected control mice (white bars). The selected genes were: CD36-CD36-like class B scavenger receptor [S. mansoni]; Sm23-Sm23 kDa integral membrane protein [S. mansoni]; Sm14-Fatty acid-binding protein Sm14 [S. mansoni]; Superox-Superoxide dismutase [S. mansoni]; TGF-beta RIP-TGF-beta receptor interacting protein 1 [C. sinensis]; B-cell RAP-B-cell receptor-associated protein-like protein [S. mansoni]. Statistically significant differences of vaccinated mice compared to PBS+adjuvant control group is denoted by one asterisk (p<0.03).
###end p 77
###begin title 78
Putative identity, categories of biological function and fold change of a subset of down-regulated genes identified in worms recovered from animals vaccinated with rSm29 associated to adjuvant.
###end title 78
###begin p 79
statistically significant, q<0.01
###end p 79
###begin title 80
Discussion
###end title 80
###begin p 81
###xml 206 216 206 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Braschi1">[11]</xref>
###xml 206 216 <span type="species:ncbi:6183">S. mansoni</span>
###xml 395 401 <span type="species:ncbi:10090">murine</span>
Schistosomiasis is one of the most important neglected tropical diseases (NTDs), and an effective control is unlikely in the absence of improved sanitation and a vaccine. Recently, the tegument proteome of S. mansoni was characterized, and one study in particular revealed the major proteins that are exposed on live adult parasites such as SmTSP-2 and Sm29 [11]. In this study, we investigated murine humoral and cellular immune responses to rSm29 and tested this molecule as a vaccine candidate.
###end p 81
###begin p 82
###xml 232 242 232 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Coulson1">[24]</xref>
###xml 232 242 <span type="species:ncbi:6183">S. mansoni</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
The strategic localization of Sm29 in the mammalian skin-stage and lung-stage schistosomula and its absence in cercariae suggests that this antigen has an important role in the adaptation of the parasite to the new environment when S. mansoni enters the mammalian host. Previous studies using mice vaccinated with irradiated cercariae showed that the lung is the key site of elimination of this parasite [24]. Sm29 localization on the surface of schistosomula is an important aspect of this antigen regarding its protective properties.
###end p 82
###begin p 83
###xml 170 177 170 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000308-t001">Table 1</xref>
###xml 580 584 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Hewitson1">[25]</xref>
###xml 775 779 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Smythies1">[26]</xref>
###xml 982 986 962 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Wilson1">[27]</xref>
###xml 1157 1161 1137 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Medzhitov1">[28]</xref>
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
###xml 567 573 <span type="species:ncbi:10090">murine</span>
###xml 836 840 <span type="species:ncbi:10090">mice</span>
###xml 959 965 <span type="species:ncbi:10090">murine</span>
###xml 1081 1085 <span type="species:ncbi:10090">mice</span>
###xml 1272 1276 <span type="species:ncbi:10090">mice</span>
In the mouse model, rSm29 induced high levels of anti-Sm29 IgG after the second immunization and showed reduced IgG1/IgG2a ratio at 45 days after the first immunization (Table 1). This finding suggests a tendency of a Th1 type of immune response induced by rSm29 vaccination. Further, we confirmed by cytokine analysis that rSm29 immunization elicited a Th1-type of immune response characterized by high levels of IFN-gamma and no IL-4 and 51% of worm burden reduction. The involvement of IFN-gamma in protective immunity to schistosomiasis is well documented in the murine model [25]. In the irradiated cercariae vaccination model, which induces high levels of protection, treatment with monoclonal anti-IFN-gamma antibody totally abrogated the protective immunity achieved [26]. Similar results were obtained using IFN-gamma knockout mice exposed to the radiation-attenuated vaccine confirming the essential role of IFN-gamma in protective immunity against murine schistosomiasis [27]. Further, we tested the ability of rSm29 to induce IL-12 in peritoneal macrophages of TLR4 KO mice. TLR4 is the major receptor for macrophage activation by bacterial LPS [28]. Therefore, using TLR4 KO we obviated any possible effect of LPS contamination in IL-12 synthesis. In TLR4 KO mice, rSm29 has induced the production of large amounts of IL-12 that is the key cytokine involved in Th1 cell development.
###end p 83
###begin p 84
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Wynn2">[29]</xref>
###xml 862 866 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Sadler1">[30]</xref>
###xml 867 871 867 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Hogg1">[31]</xref>
###xml 68 74 <span type="species:ncbi:10090">murine</span>
###xml 242 248 <span type="species:ncbi:10090">murine</span>
Pathology which results from granuloma formation around the eggs in murine schistosomiasis is characterized by Th2-type of immune response and the granuloma size can be reduced by neutralization of IL-4 [29]. Thus, morbidity and mortality in murine schistosomiasis were hypothesized to be developed as a direct consequence of the egg-induced Th2 type of immune response. Herein, the intestinal egg numbers was reduced (60%) following rSm29 vaccination compared to control group. Additionally, the immune response elicited by Sm29 was associated with 50% reduction in granuloma counts. Since we detected IL-10 production following splenocyte activation with rSm19, we hypothesize here that this cytokine might be regulating Th2 responses and/or preventing the development of highly polarized Th1 responses and therefore, reducing inflammation and liver pathology [30],[31].
###end p 84
###begin p 85
###xml 59 69 59 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 59 69 <span type="species:ncbi:6183">S. mansoni</span>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
In order to investigate the impact of rSm29 vaccination on S. mansoni, worms that were recovered from vaccinated mice had their gene expression profile analyzed using microarrays. In worms recovered from mice vaccinated with adjuvanted rSm29 when compared to a control group injected with adjuvanted phosphate-buffered saline, 495 genes (96%) were down-regulated and only 22 genes (4%) were up-regulated. Among down-regulated genes, many of them encode surface antigens and proteins associated with immune signals suggesting that under immune attack schistosomes reduce the expression of critical surface proteins. We propose here that down-regulation of expression of important surface antigens is an important strategy of the parasite resulting in escape from host immune surveillance.
###end p 85
###begin p 86
###xml 15 22 15 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000308-t003">Table 3</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Brito1">[32]</xref>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Kster1">[33]</xref>
###xml 517 521 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Khalife1">[34]</xref>
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Fonseca2">[35]</xref>
###xml 618 622 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Dadara1">[36]</xref>
###xml 795 799 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Tran1">[37]</xref>
###xml 971 975 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Cook1">[38]</xref>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 314 320 <span type="species:ncbi:9606">humans</span>
###xml 503 511 <span type="species:ncbi:9606">patients</span>
###xml 580 586 <span type="species:ncbi:10090">murine</span>
###xml 825 829 <span type="species:ncbi:10090">mice</span>
As observed in Table 3, Sm23, tetraspanin TE736 (a paralog of Sm-TSP-2), Sm14, Sm65 and superoxide dismutase are significantly (q<0.01) down-regulated in adult-worms recovered from rSm29 protected mice; it is noteworthy that these genes encode important schistosome antigens that are recognized by immune mice and humans. Sm14 is able to induce cellular immune responses in individuals from endemic areas for schistosomiasis [32]. Sm23 and Sm65 are antigens recognized by sera from schistosome infected patients [33],[34]. Moreover, Sm14 and Sm23 induce partial protection in the murine model for schistosomiasis [35],[36]. Regarding tetraspanins, they belong to a family of membrane proteins, such as Sm-TSP-2, that is currently one of the most important vaccine candidates for schistosomiasis [37]. Further, vaccination of mice with naked DNA construct containing Cu/Zn cytosolic superoxide dismutase showed significant levels of protection compared to a control group [38].
###end p 86
###begin p 87
###xml 151 159 151 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pntd.0000308.s002">Table S1</xref>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
It is noteworthy that no significant up-regulation of heat shock or chaperone genes was detected in schistosomes recovered from rSm29 vaccinated mice (Table S1), therefore excluding a common stress response. Rather, lowering the expression of critical surface antigens seems to be an important and specific strategy developed by schistosomes to reduce the damage caused by the host immune system. Therefore, a combined antigen vaccination with Sm29 and one or more of the proteins encoded by these down-regulated critical surface antigens might be the next logical step, thus circumventing the adaptive response of the parasite and eventually boosting the protective effect of vaccination.
###end p 87
###begin p 88
###xml 32 39 32 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000308-t003">Table 3</xref>
###xml 690 694 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Dinguirard1">[39]</xref>
###xml 794 804 791 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 794 804 <span type="species:ncbi:6183">S. mansoni</span>
Among the down-regulated genes (Table 3) were those encoding protein domains from TGF-beta receptor interacting protein, B-cell receptor-associated protein, CD36-like class B scavenger receptor, all of which are associated with host immune response. These parasite gene products could interact with or modulate the host immune response. For example, the scavenger receptors are present on different cells such as macrophages, platelets and neutrophils where they are involved with innate immunity by facilitating phagocytosis, cell adhesion and pathogen recognition. Recently, it was demonstrated that schistosome CD36-like class B scavenger receptor binds to host low density lipoproteins [39]. From the parasite perspective, it would not be difficult to envisage that a reduced expression of S. mansoni scavenger receptor-like molecules would decrease pathogen recognition and cell adhesion by host cells.
###end p 88
###begin p 89
###xml 171 179 171 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pntd.0000308.s002">Table S1</xref>
###xml 246 248 246 248 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In</underline>
###xml 254 255 254 255 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</underline>
###xml 262 263 262 263 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 298 308 298 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Venancio1">[40]</xref>
###xml 416 426 416 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Vandewaa1">[41]</xref>
###xml 895 899 895 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Dillon1">[42]</xref>
###xml 1319 1323 1319 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Dillon1">[42]</xref>
###xml 298 308 <span type="species:ncbi:6183">S. mansoni</span>
###xml 416 426 <span type="species:ncbi:6183">S. mansoni</span>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
Additionally, we found down-regulated genes involved with parasite carbohydrate and lipid metabolism, protein biosynthesis, intracellular signaling cascade, among others (Table S1). Down-regulated genes include SmINSIG (an ortholog of the mammal Insulin Induced Gene), a recently described gene in S. mansoni[40] that has a key role in HMG-CoA reductase degradation. HMG-CoA reductase is vital for egg production by S. mansoni[41]. An alternative hypothesis to our findings is that down-regulation of these genes may affect the development or survival of parasites in vaccinated animals, thus reducing worm burden, although the worms recovered from mice vaccinated with adjuvanted rSm29 are morphologically similar to those recovered from control mice. Additionally, haemoglobinases and Sm29 gene expression were unaltered in worms recovered from rSm29 immunized animals. Recently, Dillon et al [42] in an attempt to identify antigens responsible for protection induced by irradiated-cercariae vaccination performed microarray expression analysis of irradiated and normal worms. These investigators detected down-regulation of genes involved in neuromuscular activity and cell cycle. Their hypothesis is that attenuated parasite might have an extended stay in the host enhancing immune priming against exposed antigens [42]. Their findings may explain why irradiated-cercariae can elicit protective immunity when normal cercariae do not.
###end p 89
###begin p 90
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Tran1">[37]</xref>
###xml 451 463 451 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. japonicum</italic>
###xml 599 611 599 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. japonicum</italic>
###xml 611 615 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-Cardoso3">[43]</xref>
###xml 943 947 943 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000308-McManus1">[44]</xref>
###xml 451 463 <span type="species:ncbi:349478|species:ncbi:203021|species:ncbi:208694|species:ncbi:267983|species:ncbi:6182|species:ncbi:64971|species:ncbi:210175|species:ncbi:373705|species:ncbi:62337|species:ncbi:3897|species:ncbi:332056">S. japonicum</span>
###xml 599 611 <span type="species:ncbi:349478|species:ncbi:203021|species:ncbi:208694|species:ncbi:267983|species:ncbi:6182|species:ncbi:64971|species:ncbi:210175|species:ncbi:373705|species:ncbi:62337|species:ncbi:3897|species:ncbi:332056">S. japonicum</span>
###xml 826 831 <span type="species:ncbi:9606">human</span>
###xml 1099 1105 <span type="species:ncbi:10090">murine</span>
Recent advances in antigen discovery with preclinical studies showing promising efficacy have reinvigorated the case for a schistosomiasis vaccine. The irradiated-cercariae vaccine and the use of recombinant antigens, such as Sm-TSP-2 and Sm29, that induce approximately 50% worm burden reduction, have demonstrated that a vaccine to schistosomes is achievable [37]. Furthermore, we identified an ortholog of Sm29 in the ESTs of the Asian schistosome S. japonicum that shares more than 50% identity in the amino acid sequence, indicating that a vaccine based on Sm29 might also be effective against S. japonicum[43]. Another important issue is the selection of a suitable adjuvant and/or delivery system to induce the appropriate immune responses. Herein, we used rSm29 with Freund́s adjuvant, however, it is not suitable for human application. Experiments are underway testing rSm29 with CpG or CpG plus alum as suggested by McManus & Loukas [44]. As a final conclusion of this work, we believe that Sm29 is an efficient vaccine candidate against schistosomiasis in light of the data obtained from murine studies. The best long-term strategy to control schistosomiasis might be immunization with anti-Sm29 vaccine associated with other protective surface antigens and possibly combined with drug treatment.
###end p 90
###begin title 91
Supporting Information
###end title 91
###begin p 92
Immunolocaliztion of Sm29 on cercariae by confocal microscopy
###end p 92
###begin p 93
(0.02 MB PDF)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin p 95
Complete list of all genes and fold-changes determined by microarray analysis
###end p 95
###begin p 96
(0.15 MB PDF)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin p 98
List of primers used for validation by real-time RT-PCR
###end p 98
###begin p 99
(0.04 MB PDF)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin p 101
Movie of confocal microscopy images. Immunolocalization of Sm29 on the tegument of male adult worm. File is in AVI format.
###end p 101
###begin p 102
(7.04 MB ZIP)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin title 104
References
###end title 104
###begin article-title 105
Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa.
###end article-title 105
###begin article-title 106
###xml 100 106 <span type="species:ncbi:9606">people</span>
Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk.
###end article-title 106
###begin article-title 107
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis.
###end article-title 107
###begin article-title 108
Chemotherapeutic approaches to schistosomes: current knowledge and outlook.
###end article-title 108
###begin article-title 109
Schistosomiasis vaccine development: Progress and Prospects.
###end article-title 109
###begin article-title 110
Schistosomiasis: from risk assessment to control.
###end article-title 110
###begin article-title 111
Schistosomiasis.
###end article-title 111
###begin article-title 112
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.
###end article-title 112
###begin article-title 113
###xml 35 46 35 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma</italic>
###xml 29 34 <span type="species:ncbi:9606">human</span>
Transcriptomics tool for the human Schistosoma blood flukes using microarray gene expression profiling.
###end article-title 113
###begin article-title 114
###xml 56 75 56 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 56 75 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Use of a 44k oligoarray to explore the transcriptome of Schistosoma mansoni adult worms.
###end article-title 114
###begin article-title 115
###xml 59 78 59 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 59 78 <span type="species:ncbi:6183">Schistosoma mansoni</span>
The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction.
###end article-title 115
###begin article-title 116
###xml 59 78 59 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 59 78 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Protein synthesis and release by cultured schistosomula of Schistosoma mansoni.
###end article-title 116
###begin article-title 117
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 0 19 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Schistosoma mansoni: defined system for stepwise transformation of cercaria to schistosomule in vitro.
###end article-title 117
###begin article-title 118
###xml 94 113 94 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 94 113 <span type="species:ncbi:6183">Schistosoma mansoni</span>
IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway.
###end article-title 118
###begin article-title 119
###xml 45 55 45 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella</italic>
###xml 89 108 89 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 89 108 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Oral administration of a live Aro attenuated Salmonella vaccine strain expressing 14-kDa Schistosoma mansoni fatty acid-binding protein induced partial protection against experimental schistosomiasis.
###end article-title 119
###begin article-title 120
###xml 18 37 18 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 18 37 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine.
###end article-title 120
###begin article-title 121
###xml 49 68 <span type="species:ncbi:6183">Schistosoma mansoni</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis.
###end article-title 121
###begin article-title 122
###xml 103 122 103 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 103 122 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Gender biased differential alternative splicing patterns of the transcriptional cofactor CA150 gene in Schistosoma mansoni.
###end article-title 122
###begin article-title 123
###xml 56 75 56 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 56 75 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni.
###end article-title 123
###begin article-title 124
Design issues for cDNA microarray experiments.
###end article-title 124
###begin article-title 125
Significance analysis of microarrays applied to the ionizing radiation response
###end article-title 125
###begin article-title 126
Considerations when using the significance analysis of microarrays (SAM) algorithm.
###end article-title 126
###begin article-title 127
###xml 126 145 126 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 126 145 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni.
###end article-title 127
###begin article-title 128
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Recruitment of lymphocytes to the lung through vaccination enhances the immunity of mice exposed to irradiated schistosomes.
###end article-title 128
###begin article-title 129
Immunity induced by the radiation-attenuated schistosome vaccine.
###end article-title 129
###begin article-title 130
###xml 101 120 101 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 101 120 <span type="species:ncbi:6183">Schistosoma mansoni</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
Monoclonal antibody to IFN-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae.
###end article-title 130
###begin article-title 131
###xml 131 150 127 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 131 150 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Impaired Immunity and altered pulmonary response in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine.
###end article-title 131
###begin article-title 132
Recognition of microorganisms and activation of the immune response.
###end article-title 132
###begin article-title 133
Cytokine regulation of granuloma formation in schistosomiasis.
###end article-title 133
###begin article-title 134
###xml 102 121 102 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 102 121 <span type="species:ncbi:6183">Schistosoma mansoni</span>
IL-10 is crucial for the transition from acute to chronic disease state during infection of mice with Schistosoma mansoni.
###end article-title 134
###begin article-title 135
IL-10 regulates early IL-12-mediated immune responses induced by the radiation-attenuated schistosome vaccine.
###end article-title 135
###begin article-title 136
###xml 186 205 186 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 186 205 <span type="species:ncbi:6183">Schistosoma mansoni</span>
CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein.
###end article-title 136
###begin article-title 137
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 0 19 <span type="species:ncbi:6183">Schistosoma mansoni</span>
###xml 41 46 <span type="species:ncbi:9606">human</span>
Schistosoma mansoni: immunoreactivity of human sera with the surface antigen Sm23.
###end article-title 137
###begin article-title 138
###xml 34 53 34 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 34 53 <span type="species:ncbi:6183">Schistosoma mansoni</span>
###xml 109 114 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Molecular characterization of two Schistosoma mansoni proteins sharing common motifs with the vif protein of HIV-1.
###end article-title 138
###begin article-title 139
###xml 58 77 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone.
###end article-title 139
###begin article-title 140
###xml 146 150 <span type="species:ncbi:10090">mice</span>
Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice.
###end article-title 140
###begin article-title 141
###xml 31 50 31 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 31 50 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis.
###end article-title 141
###begin article-title 142
###xml 30 49 30 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 30 49 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage.
###end article-title 142
###begin article-title 143
###xml 145 164 145 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 145 164 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Potential role of a CD36-like class B scavenger receptor in the binding of modified low-density lipoprotein (acLDL) to the tegumental surface of Schistosoma mansoni sporocysts.
###end article-title 143
###begin article-title 144
###xml 12 31 12 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 12 31 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Analysis of Schistosoma mansoni genes shared with Deuterostomia and with possible roles in host interactions. BMC Genomics.
###end article-title 144
###begin article-title 145
###xml 72 91 72 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 72 91 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Physiological role of HMG-CoA reductase in regulating egg production by Schistosoma mansoni.
###end article-title 145
###begin article-title 146
Altered patterns of gene expression underlying the enhanced immunogenicity of radiation-attenuated schistosomes.
###end article-title 146
###begin article-title 147
###xml 24 43 24 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 24 43 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Identification of a new Schistosoma mansoni membrane-bound protein through bioinformatic analysis.
###end article-title 147
###begin article-title 148
Current status of vaccines for schistosomiasis.
###end article-title 148
###begin p 149
The authors have declared that no competing interests exist.
###end p 149
###begin p 150
This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and FINEP/SEBRAE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 150

